and it's the commercial partnerships which will get investor interest
For a company with this product, it's credentials and the team backing it, sitting back and waiting for dollars to roll in first to do a PE ratio valuation might end up being a very lousy strategy.
it could be the next NAN max for me the best time to pile in is when no one else is interested!
Good luck all.
Ann: Stage 2 of Clinical Trial Activated, page-20
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.10 |
Change
-0.120(5.41%) |
Mkt cap ! $179.3M | |||
| Open | High | Low | Value | Volume |
| $2.15 | $2.17 | $2.07 | $25.34K | 11.94K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 318 | $2.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.22 | 1374 | 2 |
View Market Depth
| Last trade - 16.10pm 05/09/2024 (20 minute delay) ? |
| EMV (ASX) Chart |